Thu, November 16, 2023
Wed, November 15, 2023
Tue, November 14, 2023
Mon, November 13, 2023
Sun, November 12, 2023
Fri, November 10, 2023

David Amsellem Downgraded (CARA) to Hold and Decreased Target to $1 on, Nov 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-1-on-nov-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Downgraded "Cara Therapeutics, Inc." (CARA) to Hold and Decreased Target from $12 to $1 on, Nov 14th, 2023.

David has made no other calls on CARA in the last 4 months.



There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 19th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Tuesday, August 8th, 2023

Publication Contributing Sources